secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evommune, Inc. (EVMN)
CIK:        0002044725
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001193125-26-049888
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evommune announces $125M private placement of 4.5M shares at $27.88/share
-------------------------------------------------------------------------

- Gross proceeds ~$125M from sale of 4,494,279 shares at $27.88 per share to institutional investors.
- Investors include new and existing mutual funds and dedicated healthcare funds.
- Net proceeds to advance clinical development programs and for general corporate purposes.
- Transaction expected to close on or about February 17, 2026, subject to customary conditions.
- Registration rights agreement filed; resale registration statement to be filed within 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2044725/000119312526049888/0001193125-26-049888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2044725/000119312526049888/evmn-20260212.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-049888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer